Arylalkyl and aryloxyalkyl phosphonates and use as antiviral age

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260941, 260951, 260952, 424212, A01N 936, C07F 940

Patent

active

041827597

ABSTRACT:
Arylalkyl and aryloxyalkylphosphonates, useful as antiviral agents, are prepared by reacting an arylalkyl or aryloxyalkyl halide with a trialkyl phosphite, or with an alkali metal salt of a dialkyl phosphonate, trialkyl phosphonoalkanoate or dialkyl phosphonoalkanone.

REFERENCES:
patent: 2934507 (1960-04-01), Chadwick et al.
patent: 3917718 (1975-11-01), Collins
patent: 4031246 (1977-06-01), Collins et al.
Baron et al., "Annual Reports in Medicinal Chemistry", Chapter on Antiviral Agents, vol. 10, (1970), p. 166.
Linn et al., "J. Am. Chem. Soc.", vol. 87 (1965), pp. 3657-3672.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Arylalkyl and aryloxyalkyl phosphonates and use as antiviral age does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Arylalkyl and aryloxyalkyl phosphonates and use as antiviral age, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylalkyl and aryloxyalkyl phosphonates and use as antiviral age will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1941086

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.